Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
S
Saki Fukuda
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2019–2024); Tottori University (2020–2025)
4 h-index
9 pubs
94 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Saki Fukuda's research focuses on the pharmacological effects of opioids and related compounds, often utilizing animal models to investigate mechanisms of action and potential therapeutic interventions. Recent work includes the development of automated methods for quantifying opioid withdrawal symptoms in neonatal rat pups and the pharmacological characterization of fentanyl analogs. Fukuda has also investigated the antidepressant effects of medium-chain triglycerides and the use of deuterated buprenorphine to mitigate fentanyl's impact in pregnant rats. This research contributes to understanding substance abuse, pain management, and maternal health. Fukuda has published nine papers with 89 citations and an h-index of 4. Key collaborators include Lisa K. Brents, William E. Fantegrossi, Kyle Urquhart, and Michael D. Berquist, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 4
- Publications: 9
- Citations: 94
Selected Publications
-
In vitro and in vivo pharmacological characterization of fentanyl analogs (2025)
-
Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software (2021)
-
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity (2020)
-
Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships (2019)
-
Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects (2018)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas Medical Center
4 shared publications
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
- In vitro and in vivo pharmacological characterization of fentanyl analogs
- Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships
- Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects
Jyoti Gogoi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
- Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects
Takato Hiranita
Florida College (US)
2 shared publications
- In vitro and in vivo pharmacological characterization of fentanyl analogs
- Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects
Anna O. Pinson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Azure L. Yarbrough
University of Arkansas at Little Rock
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
John M. Bush
University of Arkansas at Little Rock
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Christian V. Cabanlong
University of Arkansas for Medical Sciences (US)
1 shared publication
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Amal Shoeib
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Bailey K. Jackson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Keith R. McCain
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Paul L. Prather
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Ryoichi Fujiwara
University of Arkansas for Medical Sciences (US)
1 shared publication
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
Hanna J. Kulbeth
University of Arkansas for Medical Sciences (US)
1 shared publication
- Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software
Lisa K. Brents
University of Arkansas for Medical Sciences
1 shared publication
In database
- Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software
Similar Researchers
Based on overlapping research topics
Brian J. Parks
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Christopher S. Cargile
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
J. Benjamin Guise
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
RW Hall
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Maternal and Perinatal Health Interventions
Jackson W Weaver
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
John T. Striednig
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes